White label ELPA - ClinicalTrials.eu

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Not recruiting

3 1 1
Investigated diseases:
- Chronic spontaneous urticaria
Investigated drugs:
- Omalizumab
Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

Not recruiting

2 1 1 1
Investigated diseases:
- Schizophrenia
Investigated drugs:
- Rituximab
Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

Not recruiting

3 1
Investigated diseases:
- Cutaneous lupus erythematosus
Investigated drugs:
- Anifrolumab
+7
Study of Sitravatinib and Nivolumab vs. Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Chemotherapy and Checkpoint Inhibitor Therapy

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on the Effectiveness of Botulinum Toxin Type A for Patients with Cervical Dystonia and Abnormal Muscle Activity

Not recruiting

3 1 1
Investigated diseases:
- Torticollis
Investigated drugs:
Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality

Not recruiting

3 1
Investigated diseases:
- Pulmonary arterial hypertension
Investigated drugs:
- Sotatercept
Study on the Effects of AZD3427 on Kidney Function in Heart Failure Patients with Kidney Issues

Not recruiting

1 1 1
Investigated diseases:
- Heart failure with reduced ejection fraction
- Renal impairment
Investigated drugs:
Study on Darolutamide and Capecitabine for Patients with Advanced Triple-Negative Androgen Receptor Positive Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
- Capecitabine
- Darolutamide
Study of Niraparib and Dostarlimab with Radiotherapy for Patients with Locally-Advanced Head and Neck Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Niraparib
- Dostarlimab
Study of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis

Not recruiting

2 1 1 1 1
Investigated diseases:
- Myelofibrosis
Investigated drugs:
- 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
- Ruxolitinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies